AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

admin
April 24, 2026

Liked this post? Share with others!

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

Subscribe to our newsletter

We will keep you updated with our weekly roundup of all the latest happenings. Its the only news you'll need

Do you want to boost your business today?

This is your chance to invite visitors to contact you. Tell them you’ll be happy to answer all their questions as soon as possible.